摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tris-(4-anilino-3-methyl-phenyl)-methane | 861318-91-4

中文名称
——
中文别名
——
英文名称
tris-(4-anilino-3-methyl-phenyl)-methane
英文别名
4.4'.4''-Trianilino-3.3'.3''-trimethyl-triphenylmethan;Tris-(4-anilino-3-methyl-phenyl)-methan
tris-(4-anilino-3-methyl-phenyl)-methane化学式
CAS
861318-91-4
化学式
C40H37N3
mdl
——
分子量
559.754
InChiKey
ZGNXPMIUDOIKEL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    11.02
  • 重原子数:
    43.0
  • 可旋转键数:
    9.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    36.09
  • 氢给体数:
    3.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    盐酸tris-(4-anilino-3-methyl-phenyl)-methane 、 alkaline earth salt of/the/ methylsulfuric acid 生成 4.4'.4''-Trianilino-3.3'.3''-trimethyl-triphenylcarbinol
    参考文献:
    名称:
    Debasement and faking bad on the Millon Clinical Multi-axial Inventory III: An examination of characteristics, circumstances and motives of forensic patients
    摘要:
    Purpose. This article constitutes the first effort to consider debasement employing the Millon Clinical Multi‐axial Inventory III (MCMI‐III) in a forensic clinical population and incorporating the recommendations of Van Denburg and Choca (1997). It considers the proposition (Rogers, 1990a) that the pathogenic and criminological models of malingering can be rejected in favour of the adaptional model. Methods. A total of 142 MCMI‐III profiles were collected over a 17‐month period by a forensic psychology service. Of these, 47 had Debasement scale scores greater than 74. From the remaining 75, a group of 47 were randomly selected for comparative purposes. Of the total sample there were 75 males and 19 females, 68 were out‐patients and 26 were in‐patients, the latter having been detained under the Mental Health Act 1983, applicable to England and Wales. The two groups were compared on personality variables, offending history, presenting problems and referral circumstances. Results. There is tentative support for Rogers (1990a) in that situational variables appear to have a significant impact on debasement as would be predicted by the adaptional model of malingering. However, this was insufficient evidence to reject the pathogenic and criminological models of malingering. Conclusions. It is suggested that a longitudinal study examining the impact of different stages of the mental health or criminal justice system on debasement, and other validity scales, would illuminate the adaptional model further. Factors that influence the inclination to exaggerate psychopathology and which could be manipulated experimentally are also noted. Some speculation about the possible combined use of Debasement and Histrionic, Narcissistic and Compulsive scales in distinguishing between malingerers is offered.
    DOI:
    10.1348/135532500167985
  • 作为产物:
    描述:
    Tris-(4-methoxy-3-methyl-phenyl)-methanol 在 溶剂黄146 作用下, 生成 tris-(4-anilino-3-methyl-phenyl)-methane
    参考文献:
    名称:
    Debasement and faking bad on the Millon Clinical Multi-axial Inventory III: An examination of characteristics, circumstances and motives of forensic patients
    摘要:
    Purpose. This article constitutes the first effort to consider debasement employing the Millon Clinical Multi‐axial Inventory III (MCMI‐III) in a forensic clinical population and incorporating the recommendations of Van Denburg and Choca (1997). It considers the proposition (Rogers, 1990a) that the pathogenic and criminological models of malingering can be rejected in favour of the adaptional model. Methods. A total of 142 MCMI‐III profiles were collected over a 17‐month period by a forensic psychology service. Of these, 47 had Debasement scale scores greater than 74. From the remaining 75, a group of 47 were randomly selected for comparative purposes. Of the total sample there were 75 males and 19 females, 68 were out‐patients and 26 were in‐patients, the latter having been detained under the Mental Health Act 1983, applicable to England and Wales. The two groups were compared on personality variables, offending history, presenting problems and referral circumstances. Results. There is tentative support for Rogers (1990a) in that situational variables appear to have a significant impact on debasement as would be predicted by the adaptional model of malingering. However, this was insufficient evidence to reject the pathogenic and criminological models of malingering. Conclusions. It is suggested that a longitudinal study examining the impact of different stages of the mental health or criminal justice system on debasement, and other validity scales, would illuminate the adaptional model further. Factors that influence the inclination to exaggerate psychopathology and which could be manipulated experimentally are also noted. Some speculation about the possible combined use of Debasement and Histrionic, Narcissistic and Compulsive scales in distinguishing between malingerers is offered.
    DOI:
    10.1348/135532500167985
点击查看最新优质反应信息

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 重氮四苯基乙烷 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲醇,2-氨基-5-氯-a-乙烯基-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲酸,3-[[2-[[(1,1-二甲基乙氧基)羰基]氨基]-3-[(三苯代甲基)硫代]丙基]氨基]-,(R)- 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 苄基 2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷 芴甲氧羰基-4-叔丁酯-天冬酰胺-S-三氯苯甲基-L-半胱氨酸 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磺基琥珀酰亚胺基-4-[2-(4,4-二甲氧基三苯甲基)]丁酸酯 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-6-O-三苯甲基-beta-D-吡喃半乳糖苷 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷